Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

PROPAQ ENCORE MODELS 202, 204, 206; PROPAQ CS MODELS 242, 244, 246

K-Number: K012451 · 2001-08-20

ApplicantWelch Allyn Protocol, Inc.
Decision Date2001-08-20
Product CodeDRT
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

PROPAQ ENCORE MODELS 202, 204, 206; PROPAQ CS MODELS 242, 244, 246 is the device name listed in this FDA 510(k) record. The listed applicant is Welch Allyn Protocol, Inc.. It received FDA 510(k) clearance on 2001-08-20 under 510(k) number K012451. The device is classified under product code DRT. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the PROPAQ ENCORE MODELS 202, 204, 206; PROPAQ CS MODELS 242, 244, 246?

PROPAQ ENCORE MODELS 202, 204, 206; PROPAQ CS MODELS 242, 244, 246 is a medical device that received FDA 510(k) clearance on 2001-08-20. The listed applicant is Welch Allyn Protocol, Inc.. The 510(k) number is K012451.

When did PROPAQ ENCORE MODELS 202, 204, 206; PROPAQ CS MODELS 242, 244, 246 receive FDA 510(k) clearance?

PROPAQ ENCORE MODELS 202, 204, 206; PROPAQ CS MODELS 242, 244, 246 received FDA 510(k) clearance on 2001-08-20, under 510(k) number K012451.

Who is the listed applicant for PROPAQ ENCORE MODELS 202, 204, 206; PROPAQ CS MODELS 242, 244, 246?

The FDA 510(k) record lists Welch Allyn Protocol, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for PROPAQ ENCORE MODELS 202, 204, 206; PROPAQ CS MODELS 242, 244, 246?

The FDA product code for PROPAQ ENCORE MODELS 202, 204, 206; PROPAQ CS MODELS 242, 244, 246 is DRT.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Welch Allyn Protocol, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K070204LINK TO ACUITY CLINICIAN NOTIFIERK063419MODIFICATION TO VSM- VITAL SIGNS MONITOR, (VSM 300 )K033378VITAL SIGNS MONITOR, PROPAQ LTK031740VSM - VITAL SIGNS MONITOR, MODEL 53000 SERIESK022453MODIFICATION TO ACUITY CENTRAL MONITORING SYSTEMK021681MICROPAQ, MODELS 402, 404

View all 7 devices →

Related Devices (Code: DRT)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K254058DistaSense(TM) (v1)Life Detection TechnologiesK261286The Circadia C300 System (C300)Circadia Health, Inc.K252676The Circadia C300 System (C300)Circadia Health, Inc.K253388Sleepiz One+ (Model 2.5)Sleepiz AGK251364Sleepiz One+ (2.5)Sleepiz AGK234003The Circadia C200 SystemCircadia Technologies, Ltd.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑